Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Dr. Mulhall, director of Memorial Sloan-Kettering’s Male Sexual and Reproductive Medicine Program, explains common concerns about male sexual health and offers advice for men and their partners.

Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, tingling, and pain — is a common chemotherapy side effect. Treatments are available to help improve your quality of life.

Chief of the Leukemia Service Dr. Tallman discusses how experts collaborate to deliver the most-promising therapies, and how he cares for patients as if they were members of his own family.

Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

Dr. Deasy, Chair of the Department of Medical Physics and an expert in radiation therapy, talks about using physics to contribute to the fight against cancer.